tanshinone has been researched along with Reperfusion Injury in 22 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (4.55) | 29.6817 |
2010's | 16 (72.73) | 24.3611 |
2020's | 5 (22.73) | 2.80 |
Authors | Studies |
---|---|
Jiang, Z; Li, T; Li, Y; Liu, X; Wu, S; Zhang, P; Zhang, Q | 1 |
Tong, H; Wang, J; Wang, X; Wang, Y | 1 |
Jia, LQ; Jiang, XL; Kong, L; Kuang, JS; Lan, ZM; Li, Y; Lv, MJ; Song, N; Tai, H; Wu, J; Xiao, XS; Yang, GL; Yang, P; Yao, SC | 1 |
Cai, X; Huang, Y; Peng, X; Song, Q; Wang, B; Wang, C; Xiong, X; Ye, X; Zeng, T; Zhang, C | 1 |
Du, J; Feng, J; Hu, K; Liu, M; Wang, L; Xu, L; Zhao, X | 1 |
Cheng, Y; Gong, J; Li, X; Wu, Y; Zhang, W | 1 |
Cai, L; Gong, G; Yi, XB; Yuan, LB | 1 |
Fu, Z; Liu, F; Ni, Q; Wang, Q; Wang, Y; Ye, Q | 1 |
Jiang, W; Liu, BL; Liu, J; Qi, LW; Wang, F; Zhao, YP; Zhou, W | 1 |
Huang, LH; Li, WW; Wang, F; Wen, PY; Yang, FZ; Zhou, J; Zhou, L | 1 |
Ahn, JH; Chen, BH; Cho, JH; Choi, JH; Hwang, IK; Kim, IH; Kwon, SH; Lee, CH; Lee, JC; Lee, YL; Park, JH; Park, Ok; Won, MH; Yan, BC; Yoo, KY | 1 |
Cai, M; Dong, H; Guo, Y; Sun, S; Wang, S; Wei, H; Zhao, G | 1 |
Bai, C; Fu, R; Tang, C; Wu, A; Xue, H | 1 |
Feng, J; Li, CH; Liu, HL; Lou, JN; Peng, L; Ye, LY; Zhang, WJ; Zhou, R | 1 |
Chen, WY; Huang, M; Liu, FY; Sun, CM; Wang, HM; Zhu, BD; Zhu, GX | 1 |
Chen, T; Ding, GS; Liu, F; Mei, Y; Qi, YY; Shi, YZ; Song, SH; Tang, JM; Wang, QX; Xiao, L; Zhang, LD | 1 |
Chen, Y; Fauzee, NJ; Li, L; Wu, J; Wu, X; Yu, S; Zhao, J; Zhao, Y | 1 |
Chen, Y; Li, L; Lin, X; Wu, J; Wu, X; Yu, S; Zhao, J; Zhao, Y | 1 |
Cai, Q; Hua, SY; Li, CS; Tan, JZ; Wang, HW; Zhou, T | 1 |
Cai, Q; Huang, SY; Tan, JZ | 1 |
Chen, G; Li, X; Long, W; Mu, L; Shao, AL; Wen, L; Yang, F; Zhang, X | 1 |
Li, ZY; Liu, XL; Wang, HG | 1 |
22 other study(ies) available for tanshinone and Reperfusion Injury
Article | Year |
---|---|
Tanshinone Protects against Spinal Cord Ischemia-Reperfusion Injury by Inhibiting JNK Activity.
Topics: Abietanes; Animals; Ischemia; Phosphorylation; Rabbits; Reperfusion Injury; Spinal Cord; Spinal Cord Injuries; Spinal Cord Ischemia | 2022 |
Tanshinone IIA alleviates the damage of neurocytes by targeting GLUT1 in ischaemia reperfusion model (in vivo and in vitro experiments).
Topics: Abietanes; Animals; Brain; Brain Ischemia; Disease Models, Animal; Glucose Transporter Type 1; Mice; Mice, Inbred C57BL; Neurons; Recovery of Function; Reperfusion Injury | 2020 |
Tanshinone IIA combined with CsA inhibit myocardial cell apoptosis induced by renal ischemia-reperfusion injury in obese rats.
Topics: Abietanes; Animals; Apoptosis; Cyclosporine; DNA, Mitochondrial; Heart; Kidney; Male; Membrane Potential, Mitochondrial; Mitochondria, Heart; Mitochondrial Permeability Transition Pore; Myocytes, Cardiac; Obesity; Rats; Reactive Oxygen Species; Reperfusion Injury; Signal Transduction | 2021 |
Borneol-modified tanshinone IIA liposome improves cerebral ischemia reperfusion injury by suppressing NF-κB and ICAM-1 expression.
Topics: Abietanes; Animals; Brain Ischemia; Camphanes; Intercellular Adhesion Molecule-1; Liposomes; NF-kappa B; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 2021 |
Nose-to-brain delivery of borneol modified tanshinone IIA nanoparticles in prevention of cerebral ischemia/reperfusion injury.
Topics: Abietanes; Adjuvants, Pharmaceutic; Administration, Intranasal; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Brain; Brain Ischemia; Camphanes; Chemistry, Pharmaceutical; Delayed-Action Preparations; Disease Models, Animal; Drug Carriers; Malondialdehyde; Nanoparticles; Neuroprotective Agents; Particle Size; Polyethylene Glycols; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Reperfusion Injury; Succinimides; Superoxide Dismutase | 2021 |
Pre-conditioning with tanshinone IIA attenuates the ischemia/reperfusion injury caused by liver grafts via regulation of HMGB1 in rat Kupffer cells.
Topics: Abietanes; Animals; HMGB1 Protein; Interleukin-10; Interleukin-4; Kupffer Cells; Liver; Liver Diseases; Liver Transplantation; Male; Myeloid Differentiation Factor 88; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Phosphatidylinositol 3-Kinases; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Signal Transduction; Toll-Like Receptor 4; Transcription Factor RelA; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2017 |
[The Protective Effect of Tanshinone IIA on Oxygen-glucose Deprivation and Reperfusion Injury of MicrogliaThrough the NLRP3 Inflammatory Signaling Pathway].
Topics: Abietanes; Animals; Cell Line; Cytokines; Glucose; Mice; Microglia; NLR Family, Pyrin Domain-Containing 3 Protein; Oxygen; Reperfusion Injury; Signal Transduction | 2016 |
Tanshinone IIA activates autophagy to reduce liver ischemia-reperfusion injury by MEK/ERK/mTOR pathway.
Topics: Abietanes; Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Autophagy; Cytokines; Disease Models, Animal; Hepatocytes; Liver; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Reperfusion Injury; TOR Serine-Threonine Kinases | 2018 |
A mitochondrion-targeting tanshinone IIA derivative attenuates myocardial hypoxia reoxygenation injury through a SDH-dependent antioxidant mechanism.
Topics: Abietanes; Animals; Antioxidants; Cells, Cultured; Hypoxia; Mitochondria; Myocardial Ischemia; Rats; Reactive Oxygen Species; Reperfusion Injury; Signal Transduction; Succinate Dehydrogenase | 2019 |
[Study on regulation of tanshinone II(A) on GFAP and ATPase and PDI of cerebral ischemia reperfusion injury in rats].
Topics: Abietanes; Adenosine Triphosphatases; Animals; Brain; Brain Ischemia; Disease Models, Animal; Glial Fibrillary Acidic Protein; Immunohistochemistry; Infarction, Middle Cerebral Artery; Male; Neuroprotective Agents; Protein Disulfide-Isomerases; Random Allocation; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Rhizome; Salvia miltiorrhiza | 2012 |
Anti-inflammatory effect of tanshinone I in neuroprotection against cerebral ischemia-reperfusion injury in the gerbil hippocampus.
Topics: Abietanes; Animals; Anti-Inflammatory Agents, Non-Steroidal; Brain Ischemia; Drugs, Chinese Herbal; Gerbillinae; Hippocampus; Male; Neuroprotective Agents; Reperfusion Injury; Treatment Outcome | 2014 |
Tanshinone IIA Elicits Neuroprotective Effect Through Activating the Nuclear Factor Erythroid 2-Related Factor-Dependent Antioxidant Response.
Topics: Abietanes; Animals; Antioxidants; Apoptosis; Brain Ischemia; Cell Nucleus; Gene Knockdown Techniques; Male; Mice, Knockout; Neurons; Neuroprotective Agents; NF-E2-Related Factor 2; Oxidation-Reduction; Protein Transport; Reperfusion Injury | 2017 |
The effects of Tanshinone IIA on blood-brain barrier and brain edema after transient middle cerebral artery occlusion in rats.
Topics: Abietanes; Animals; Blood-Brain Barrier; Brain; Edema; Evans Blue; Infarction, Middle Cerebral Artery; Intercellular Adhesion Molecule-1; Ischemic Attack, Transient; Matrix Metalloproteinase 9; Membrane Proteins; Occludin; Permeability; Phenanthrenes; Phytotherapy; Plant Extracts; Plant Roots; Rats; Reperfusion Injury; Salvia miltiorrhiza; Tight Junctions; Water | 2010 |
Tanshinone IIA protects the human blood-brain barrier model from leukocyte-associated hypoxia-reoxygenation injury.
Topics: Abietanes; Blood-Brain Barrier; Culture Media, Conditioned; Electric Impedance; Endothelial Cells; Humans; Hypoxia; Leukocytes; Oxygen; Permeability; Phenanthrenes; Reperfusion Injury | 2010 |
[Effect of tanshinone IIA pretreatment on IL-1β and RelA mRNA expression in rats with focal cerebral ischemia].
Topics: Abietanes; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Brain Ischemia; Infarction, Middle Cerebral Artery; Interleukin-1beta; Male; Rats; Reperfusion Injury; RNA, Messenger; Transcription Factor RelA | 2010 |
Tanshinone IIA pretreatment attenuates hepatic ischemia-reperfusion.
Topics: Abietanes; Animals; Base Sequence; Blotting, Western; DNA Primers; Immunohistochemistry; Liver; Male; Mice; Mice, Inbred C57BL; Real-Time Polymerase Chain Reaction; Reperfusion Injury | 2012 |
Neuroprotective capabilities of Tanshinone IIA against cerebral ischemia/reperfusion injury via anti-apoptotic pathway in rats.
Topics: Abietanes; Animals; Apoptosis; Caspase 3; DNA Fragmentation; Infarction, Middle Cerebral Artery; Male; Neuroprotective Agents; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 2012 |
Neuroprotection of tanshinone IIA against cerebral ischemia/reperfusion injury through inhibition of macrophage migration inhibitory factor in rats.
Topics: Abietanes; Animals; Antigens, Nuclear; Brain Ischemia; Cerebral Infarction; Glial Fibrillary Acidic Protein; Inflammation Mediators; Intramolecular Oxidoreductases; Macrophage Migration-Inhibitory Factors; Male; Nerve Tissue Proteins; Neuroprotective Agents; Neutrophil Infiltration; Peroxidase; Protein Transport; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Time Factors; Transcription Factor RelA; Water | 2012 |
Neutroprotective efficacy of sodium tanshinone B on hippocampus neuron in a rat model of focal cerebral ischemia.
Topics: Abietanes; Animals; Brain Ischemia; Cytoprotection; Disease Models, Animal; Drug Evaluation, Preclinical; Drugs, Chinese Herbal; Hippocampus; Models, Biological; Neurons; Neuroprotective Agents; Random Allocation; Rats; Reperfusion Injury; Treatment Outcome | 2012 |
[Effects of sodium tanshinone B on the protein expression of NMDAR1 in rat hippocampal subfields following focal ischemia/reperfusion injury].
Topics: Abietanes; Animals; Brain Ischemia; Hippocampus; Male; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Reperfusion Injury | 2012 |
Novel multiple agents loaded PLGA nanoparticles for brain delivery via inner ear administration: in vitro and in vivo evaluation.
Topics: Abietanes; Animals; Benzofurans; Brain; Carotid Arteries; Drug Administration Routes; Drug Carriers; Ear, Inner; Ginsenosides; Guinea Pigs; Lactic Acid; Male; Nanoparticles; Neuroprotective Agents; Panax notoginseng; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Reperfusion Injury | 2013 |
Addition of tanshinone IIA to UW solution decreases skeletal muscle ischemia-reperfusion injury.
Topics: Abietanes; Adenosine; Adenosine Triphosphatases; Allopurinol; Animals; Apoptosis; Aspartate Aminotransferases; Creatine Kinase; Dose-Response Relationship, Drug; Glutathione; Hindlimb; Insulin; Intercellular Adhesion Molecule-1; L-Lactate Dehydrogenase; Male; Malondialdehyde; Muscle, Skeletal; Organ Preservation Solutions; Phenanthrenes; Raffinose; Random Allocation; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Superoxide Dismutase | 2006 |